Prescription Required
Medicinal compound called "Cabita 500mg Tablet" falls in the category of drugs that are widely administered in the therapy of specific health conditions, notably cancer.
The drug Capecitabine is converted into 5FU, which subsequently serves as a hindrance for a principal participant in the process of cell splitting. This blockade restrains the generation of ThMP, a significant element for the synthesis of DNA. In the absence of appropriate ThMP levels, cells encounter difficulties in producing new DNA, decelerating their replication rate. This disturbance in the cell division process forms a significant part of Capecitabine's efficacy, particularly in reference to cancer treatment.
For obtaining the best results, adhering to your physician's instructions regarding the prescribed quantity and period is paramount. Capecitabine can be consumed either with meals or without, however, sticking to a consistent daily regimen is suggested.
Typical side effects of consuming Capecitabine might include feeling of sickness, forceful expulsion of stomach contents, abdominal discomfort, loose motions, excessive tiredness, loss of body fluids, eye discomfort, problems with bowel movement, numbness or tingling sensation, and decrease in red blood cells. Being aware of these potential side effects and informing your medical practitioner if these persist or aggravate is crucial.
Intake of Capecitabine can inhibit the activity of bone marrow, which may result in reduced production of blood cells. Periodic counts of blood cells must be carried out in order to monitor conditions like shortage of red blood cells, white blood cells, and platelets. Individuals having existing problems related to kidney function must exercise caution, and dosage modifications might be needed based on kidney performance. Regular assessment of renal function is vital for patients with renal conditions.
In case a dose of Capecitabine is forgotten, it should be consumed as soon as remembered. However, if the time for the next dose is near, missing the previous dose and continuing with the regular dosage schedule is recommended. Taking two doses at the same time should be averted. Guided advice from your physician on effectively managing forgotten doses ensures correct usage of the drug and upkeep of its effectiveness.
Seek advice from your healthcare professional regarding the safe intake of alcohol while on medication as it is unclear.
Consult your doctor for alternatives as the medicine has known risks, making it unsafe for use during pregnancy.
It is advised to avoid medicine while breastfeeding since it might be toxic to the baby; consult your healthcare provider.
In cases of kidney diseases, it is advised to take the medicine with caution; your doctor may need to adjust the dose and monitor your condition.
Patients with liver disease are cautioned to use medicine under careful monitoring and potential dose adjustments by the doctor.
Imatinib metabolizes into Glivec (GLV), functioning as a barricade for a crucial participant in cellular proliferation. This blockade, GLV, pauses the synthesis of a necessary substance, kinases, required for generating cell growth signals. Without sufficient kinases, cells can't create new cellular growth signals correctly, decelerating their capacity for growth. In essence, Imatinib interferes with the cell's growth process, a significant factor in its application against specific diseases, particularly leukemia.
Breast cancer is a type of cancer that affects the cells of the breast. Breast cancer can cause symptoms such as a lump in the breast, changes in the skin or nipple, or bleeding from the nipple.Cancer of the colon and rectum, also known as colorectal cancer, is a type of cancer that affects the large intestine and the anus. Colorectal cancer can cause symptoms such as changes in bowel habits, blood in the stool, abdominal pain, weight loss, or fatigue.
Content Updated on
Thursday, 1 Feburary, 2024Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA